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Abstract
Allergic diseases in animals are increasingly gaining importance in veterinary
practice and as research models. For intradermal testing and allergen
immunotherapy, a good knowledge of relevant allergens for the individual species
is of great importance. Currently, the knowledge about relevant veterinary aller-
gens is based on sensitization rates identified by intradermal testing or serum test-
ing for allergen-specific IgE; crude extracts are the basis for most evaluations.
Only a few studies provide evidence about the molecular structure of (particu-
larly) dust mite, insect and mould allergens in dogs and horses, respectively. In
those species, some major allergens differ from those in humans. This position
paper summarizes the current knowledge about relevant allergens in dogs, cats
and horses.
Allergic diseases are frequently observed in veterinary prac-
tice. With increasing standards in veterinary care, intradermal
testing and allergen immunotherapy were introduced to small
animal practice in the mid-nineteen hundreds; later, serum
testing for allergen-specific IgE was developed for dogs, cats
and horses. Although atopic asthma is rare in the dog and
not much is known with regard to allergic rhinitis, atopic
dermatitis is a frequently encountered disease in small animal
practice and a focus of research in veterinary dermatology. It
resembles human atopic dermatitis and has been proposed as
a canine model for its human counterpart (1). Due to distinct
breed predispositions (2), a genetic base in the dog was
assumed for years and more recently has been confirmed with
gene microarray studies (3). Atopic dermatitis is regularly
observed in cats, but the clinical signs of atopic dermatitis
are very different from the disease observed in humans (4).
In contrast to dogs, feline asthma is not uncommon.
Although intradermal testing, serum testing for allergen-
specific IgE and allergen immunotherapy are used regularly
in feline patients, studies elucidating the exact pathogenesis
in this species are scarce. Horses develop skin and respiratory
disorders that have been attributed to allergy. While recur-
rent airway obstruction, previously called ‘heaves’, has many
similarities to human asthma, the best understood allergic
disease in horses is insect-bite hypersensitivity (5). An
effective treatment for this disease still remains elusive. In
contrast to human medicine, where allergen immunotherapy
is predominantly used for atopic rhinitis and asthma, allergen
immunotherapy is an accepted and frequently conducted
treatment for atopic dermatitis in the dog, cat and horse (6),
although data on the major allergens relevant for dogs, cats
and horses are limited (Table 1). In contrast to environmen-
tal allergens, studies evaluating food allergens in veterinary
medicine are rare. Food rechallenges after elimination diets
are notoriously difficult and not performed in a double-
blinded fashion. Skin and serum testing for food allergens
has been shown in many studies to be unreliable (7, 8). For
this reason, this position paper focusses on information
currently published regarding environmental allergens in
canine, feline and equine medicine.
Allergens in canine medicine
In canine allergology, dust mites are considered relevant and
important allergens. This was initially based on the high
number of positive reactions with intradermal testing against
Dermatophagoides (D.) farinae and D. pteronissynus. The
clinical relevance is further documented by a number of stud-
ies documenting the presence of mites and mite antigens in
the dogs’ environment as well as on the dogs’ skin and coat
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(9), and clinical signs and T-cell responses after exposure to
dust mite antigens in dogs sensitized to house dust mites
(10). However, skin reactivity as well as dust mite-specific
serum IgE has also been shown to be present in a high
number of normal dogs (11), indicating that sensitization is
not always associated with clinical signs. Sensitization with-
out clinical disease is also reported in humans and varies
between 13 and 36%, but in contrast to dogs, the rate of sen-
sitization is generally lower than in atopic patients (12, 13).
In some areas such as the UK, D. pteronyssinus is the pre-
dominant mite in the environment, and in other areas,
D. farinae is more commonly found. Despite these differences
in geographic prevalence, positive reactions to D. farinae are
uniformly most frequently observed in intradermal tests (14,
15). Commercially available veterinary mite allergen prepara-
tions used in practice are extracts of D. farinae and
D. pteronyssinus and are produced by a number of
companies (15). Currently, to the authors’ knowledge, recom-
binant mite allergens are not available for dogs and cats. The
available human recombinant or purified mite antigens devel-
oped for humans are not considered suitable for dogs, as the
currently identified major allergens in dogs differ from those
in humans. On Western blot, binding of IgG4 to purified
group 1 and 2 allergens was not observed in atopic dogs
reacting to intradermal crude dust mite extract (16). The
majority of atopic dogs in this study showed reactions to
allergens of higher molecular weights (68 and 90 kDa, respec-
tively). Similarly, only a minority of dust mite-allergic dogs
with IgE antibodies against D. farinae and D. pteronyssinus
had specific IgE against group 1 and group 2 allergens (17)
or specifically against Der f 1, Der f 2, Der p 1 and Der p 2
(14). Homology of a protein with 98 kDa and 555 amino
acids suggested a chitinase, which was cloned, expressed and
named Der f 15 (18). This molecule elicited positive reactions
Table 1 Allergens of documented importance in domestic animals that have been characterized at the molecular level
Allergen source Allergen name Identity/homology MW(kDa) Relevant in species References
Dermatophygoides farinae Der f 15 Chitinase 98/109 Dog (18)
Der f 18 Chitinase 60 Dog (19)
Cryptomeria japonica Cry j 1 Pectate lyase 41 Human
Dog
(32)
Cryptomeria japonica Cry j 2 Polygalacturonase 56 Human
Dog
(78)
Cryptomeria japonica Cry j 3 Thaumatin-like protein 24 Human
Dog
(32)
Ctenocephalides felis Cte f 1 None 18 Dog (36)
Culicoides nubeculosus Cul n 1 Antigen-5 like 25 Horse (70)
Cul n 2 Hyaluronidase 46.7 Horse (68)
Cul n 3 Cysteine endopeptidase 44.6 Horse (68)
Cul n 4 None 17.5 Horse (68)
Cul n 5 None 45.7 Horse (68)
Cul n 6 None 16.9 Horse (68)
Cul n 7 None 20.9 Horse (68)
Cul n 8 Maltase 68.7 Horse (68)
Cul n 9 D7-related 15.5 Horse (68)
Cul n 10 None 47.8 Horse (68)
Cul n 11 Trypsin 30.1 Horse (68)
Culicoides obsoletus Cul o 1* Maltase 66.8 Horse (79)
Cul o 2* Hyaluronidase 42.3 Horse (79)
Cul o 3 Antigen-5 like 27.9 Horse (79)
Cul o 4 Trypsin 27.1 Horse (79)
Cul o 5 None 17.9 Horse (79)
Cul o 6 D7-related 15.2 Horse (79)
Cul o 7 None 15 Horse (79)
Cul o1* Kunitz protease inhibitor 23.3 Horse (67)
Cul o 2* D7-related 17.5 Horse (67)
Culicoides sonorensis Cul s 1 Maltase 66 Horse (66)
Simulium vittatum Sim v 1 Antigen 5 like 29.8 Horse (69)
Sim v 2 Kunitz protease Inhibitor 9.6 Horse (69)
Sim v 3 A-amylase 28 Horse (69)
Sim v 4 a-amylase 26 Horse (69)
Aspergillus fumigatus Asp f 7 None 27.4 Human, horse (59, 75)
Asp f 8 Acidic P 2 ribosomal proteins 11 Human, horse (59, 60, 75)
*Nomenclature needs modification. These allergen sequences were submitted to GenBank at the same time by different groups.
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on intradermal testing in almost all atopic dogs reacting to a
crude extract of D. farinae; similarly, all sera from dogs with
antibodies against D. farinae extracts also had antibodies
against Der f 15. A 60 kDa protein, Der f 18, was purified
and showed sequence homology with other chitinases.
Approximately 80% of atopic dogs with D. farinae-specific
IgE antibodies also had antibodies against Der f 18 (19).
Both Der f 15 and Der f 18 are localized to the digestive sys-
tem of the mites. Der f 15 and Der f 18 can be considered
major dust mite allergens in the dog. A range of minor aller-
gens from 15-150 kDa were identified in dogs, but not char-
acterized in more detail (17).
Sensitivity to storage mites such as Tyrophagus putrescen-
tiae, Lepidoglyphus destructor and Acarus siro in dogs was
based on skin test reactivity against mite extracts and storage
mite-specific IgE (20, 21). Storage mites have been identified
in the dogs’ environment (22) as well as in dog food (23).
However, the amount of contamination in the dog food
seems to be dependent on optimal environmental conditions
including warm temperature and high humidity (23) and is
also influenced by the packaging material, and the duration
the package has been open. In most studies evaluating stor-
age mite sensitization, reactions against crude extracts were
measured. In one study, the major allergens confirmed were
>80 kD (20), but data on more specific identification are not
available. Whether the high rate of sensitization is clinically
relevant is not clear. There was no difference in the number
of positive intradermal reactions to Tyrophagus putrescentiae
(21) and Lepidoglyphus destructor (24) between normal dogs
and dogs with atopic dermatitis, which is similar to what is
observed in dogs sensitized to house dust mites (11). Promi-
nent cross-reactivity has been reported between house dust
and storage mite antigens in the dog (15), and exposure to
storage mites leads to clinical signs in Beagles sensitized to
house dust mites (25). This further complicates the interpreta-
tion of the clinical relevance of storage mite sensitivity.
Sensitization of dogs with atopic dermatitis against various
plant-derived allergens such as from tree, grass and weed pol-
lens was reported in several studies. In the largest study, the
incidence of positive reactions to individual grass, tree and
weed pollen extracts was between 10 and 25% (26). Those
studies evaluating possible cross-reactivities between related
and nonrelated allergen sources (27–29) came to the conclu-
sion that concurrent positive reactions among botanically
closely related plant allergens were significantly more com-
mon than those among nonrelated allergens. However, as
more than 30% of the dogs did not show positive concurrent
reactions to closely related allergens, cross-reactivity was not
pronounced enough to warrant testing and desensitization
with allergen extracts containing pollens from several differ-
ent grasses, trees or weeds. No seasonal, sex- or age-depen-
dent risk factors were observed in a recent comprehensive
study of canine grass pollen sensitization in Western France
(30). Importantly, as in humans, a significant increase in the
number of dogs sensitized to grass pollen has been observed
increasing from 14.4% (1999 and 2002) to 27.7% (2007 and
2010). More than 80% of the 262 tests were positive for at
least one allergen, and 21% to at least one pollen allergen.
Masuda et al. tested 42 Japanese atopic dogs by IDT and
IgE test using 26 allergen extracts from 8 allergen sources
(31). Japanese cedar (Cryptomeria japonica) pollen extract
was the second most important allergen extract after house
dust mite extract. Sensitization was observed in 24% of the
atopic dogs. Concentrations of IgE against Japanese cedar
pollen were above 200 U/ml in 5 of the 10 positive dogs,
whereas the other 5 remained under 60 U/ml. In a recent
approach, the sensitization to single allergen molecules from
Japanese cedar pollen was evaluated more precisely in 15
dogs. Besides IgE to Cry j 1, 76% showed IgE against Cry j
3, a major allergen in dogs (32).
Flea allergy is one of the most common allergies in the
dog. On intradermal testing, positive reactions to fleas are
more common than to any other insect (33). Serum antibod-
ies against flea antigens were isolated in dogs many years
ago. Up to half of the dogs in flea-infested environments
develop IgE antibodies against flea antigens (34). Two pro-
teins with a molecular weight of 8–12 and 40 kD were identi-
fied as relevant in dogs (35). A further protein of 18 kD was
isolated from the saliva of the cat flea, Ctenocephalides felis,
and elicited reactions in 100% of dogs sensitized to fleas and
in 80% of clinically flea-allergic dogs. This antigen was
considered a major allergen in dogs, cloned and named Cte f
1 (36).
Insect allergies other than flea allergies are relatively rare
in dogs. Local and sometimes systemic anaphylactoid and
anaphylactic reactions following hymenoptera stings have
been described (37, 38). However, the incidence of anaphylac-
tic reactions to bee or vespid stings is unknown in compan-
ion animals (39) and it is not always known whether the
reactions are immune-mediated or due to massive envenoma-
tion. To our knowledge, it is also not known whether dogs
are sensitized to the same venom allergens as human patients.
There is only sparse published information available on
hypersensitivity reactions to biting insects such as tabanids,
black fly, mosquito, deer fly, horse fly, red ant and black ant,
but clinical cases have been reported. Pruritic skin lesions are
usually located on the thinly haired areas of the body,
although there are definite regional areas of predisposition,
such as the ear tips with some biting flies. Intradermal tests
indicate sensitizations to horse flies, Culicoides spp. (midges),
Simuliidiae (black flies) but also to other insects such as
housefly, ant, deerfly and mosquito. However, intradermal
test results with insect extracts have to be interpreted care-
fully, because positive reactions to intradermal tests with
arthropods are often found in healthy control dogs at similar
frequencies as in dogs with allergic skin disease (33). In one
study, the only significant difference between control dogs
and skin-allergic dogs was found with flea extract (33).
Sensitization to mould allergens occurs in dogs with atopic
dermatitis (40). However, percentages of dogs with IgE
against fungal allergens vary considerably among studies.
These discrepancies may reflect lack of standardization in
allergen extracts used in these studies or low specificity of
available assays. Higher sensitization in North American
studies (2) than in Europe (41), Australia (26) or Asia (42)
suggested geographical influences. Mould proteases can
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degrade pollen allergens when stored in the same vial (43).
There is evidence for clinical relevance in canine immunother-
apy, as dogs with moulds in their SIT extract had a much
lower success rate than dogs in the same environment for
which the same mould extracts were stored in different
vials (44). To the authors’ knowledge, exact allergens relevant
for canine allergology have not been identified and recombi-
nant mould allergens have not been used in allergy testing in
dogs.
Allergens in feline medicine
House dust mite antigens (Der p 1, Der f 1 and group 2
allergens) were detected in households housing cats, at a con-
centration of > 2 mcg/g dust (45). This concentration is
regarded as a risk factor for the development of sensitization
in susceptible humans. Sensitization to house dust mites was
documented by intradermal testing with extracts from
D. farinae and D. pteronyssinus (46) and serum testing for
dust mite-specific IgE (47). Both clinically allergic cats and
cats with no clinical evidence of atopic disease showed the
same concentrations of D.f.-specific IgE, in contrast to speci-
fic pathogen-free cats (48). When evaluating intradermal test-
ing and testing for allergen-specific IgE using the Fc epsilon
RI alpha to capture IgE in an asthmatic cat model, no cat
showed positive results in either test prior to sensitization
with house dust mite antigens, while the majority of cats
developed positive skin test reactions after 28 days and dust
mite-specific serum IgE after 50 days (49). However,
although intradermal testing was positive more often in cats
with allergic dermatitis than in nonallergic cats (46), serum
concentrations of dust mite-specific IgE in normal cats were
not different from cats with allergic skin disease (47). There
is no information available about major and minor dust mite
allergens in feline allergic skin disease, nor is there any con-
clusive evidence for or against the involvement of storage
mites in feline allergic diseases.
Sensitization of cats against pollen antigens has been
reported in a number of studies evaluating cats with skin dis-
ease, seasonal rhinitis and asthma. Sensitization was reported
in 8.3% of asthmatic cats against orchard grass pollen, only
in 4% against birch pollen, and ragweed or mugwort pollen
sensitization was not reported (50). However, the proportion
of cats showing symptoms of allergy with positive reactions
on serum testing for allergen-specific IgE was not different
to that of healthy cats in one study (51). Similarly, compar-
ing the number of allergens with increased allergen-specific
serum IgE in atopic cats with flea-allergic cats, cats with
adverse food reactions or those with nonallergic pruritic
skin disease, no significant differences were found between
groups (52). IgE to environmental allergens including pollen
could be even found in cats housed in a pathogen-free envi-
ronment (53). Cats may also present with rhinitis, sporadi-
cally permitting the identification of causative pollen
allergens (54).
Flea allergy is the most common allergy in the cat. In one
study, the majority of cats reacting to a live flea challenge
also showed an immediate hypersensitivity on intradermal
testing with flea extracts from three manufacturers (55),
although only a few reacted to the extracts of all manufactur-
ers. Delayed-type reactions after 24 and 48 h were observed
in fewer cats, again not often uniformly reacting to the
extracts of all manufacturers (55).
Hymenoptera sting allergies seem to occur in cats (39),
but the prevalence is probably low as the authors found no
published reports on bee or vespid sting hypersensitivities in
cats. Feline mosquito bite hypersensitivity is a predomi-
nantly facial-allergic skin disease characterized by papules,
crusted papules and punctate ulcers. Lesions may also occur
on the pawpads and pinnae. Histopathologically, severe
eosinophilic inflammation in the dermis with lymphocytes,
macrophage, neutrophil and/or mast cell infiltration and an
associated eosinophilic folliculitis and furunculosis has been
reported (56). Lesions have been shown to occur at the
exact site of previous mosquito bites. An elegant study
showed that following controlled Aedes albopictus bite expo-
sure, hypersensitive cats developed wheals within 20 min of
exposure, followed by papules or small crusts after 12–48 h
in some of the cats. Healthy control cats only showed slight
and transient erythema after exposure. Similar results were
obtained in intradermal tests. Furthermore, a Prausnitz–
K€ustner tests clearly confirmed the involvement of type I
hypersensitivity reactions (56) in these mosquito bite-allergic
cats. However, detailed information on the involved aller-
gens is lacking.
The authors could not identify any reports regarding
mould allergens in feline allergic skin disease.
Allergens in equine medicine
House dust mites were reported to be present in horse rugs
in one study (57) and in another study a variety of storage
mite species were found in stables, but Dermatophagoides spe-
cies could not be identified (58). Intradermal testing and
serum testing for dust mite-specific IgE was reported in a
number of studies with variable results. In most of those
studies, crude extracts of a variety of storage mites and house
dust mites were used. In a few studies, no difference could be
observed in the sensitization to storage mite extracts between
normal horses and horses suffering from chronic bronchitis
(59), now called recurrent airway obstruction (RAO) or
heaves, an asthma-like condition of horses, caused by hyper-
sensitivity reactions to hay dust, or chronic urticaria based
on intradermal testing (60) as well as serum testing (59, 60).
Based on those studies, positive reactions to crude extracts
are not useful in the diagnosis of allergic skin or respiratory
disease. However, the concentrations of the crude extracts
used varied and threshold concentrations for intradermal
testing of horses with mite extracts have only recently been
established (58). In a retrospective study at the University of
California-Davis, successful immunotherapy, in which crude
extracts have been used for both intradermal testing and
desensitization of horses suffering from atopic dermatitis or
urticaria, has been reported (61).
The authors are not aware of any reported allergic reac-
tions following hymenoptera stings in horses. However,
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hypersensitivity reactions to insect bites occur relatively fre-
quently in this species. The best characterized allergic reac-
tion to insect bites in horses is an IgE-mediated dermatitis
caused by bites of insects of the genus Culicoides, named
insect bite hypersensitivity (IBH) or sometimes also Culi-
coides hypersensitivity, summer eczema or Queensland itch.
The genus Culicoides consists of over 500 different biting
Culicoides species. Culicoides spp. can be found worldwide,
except in Iceland. The prevalence of IBH varies between 3
and 60% depending on the environment and genetic back-
ground of the horse (62). A number of studies have shown
that IBH-affected horses more frequently have positive IDT
results with Culicoides extract and sometimes also with other
insect extracts than healthy control horses (62). The involve-
ment of Culicoides allergens in IBH has also been
demonstrated in functional in vitro tests such as sulfi-
doleukotriene release (CAST, B€uhlmann laboratories AG)
(63) or histamine release tests using C. nubeculosus, C.
sonorensis or C. obsoletus extracts (64, 65). Furthermore, sul-
fidoleukotrienes and histamine are released significantly more
frequently from IBH-affected horses than from healthy con-
trols following the stimulation of peripheral blood leucocytes
with Simulium vittatum extract (63).
Since 2009, allergens from different Culicoides species (C.
sonorensis [Cul s], C. nubeculosus [Cul n], C. obsoletus [Cul
o]) have been characterized at the molecular level and
expressed as recombinant protein (Table 1) (65–68). Some of
these Culicoides allergens are homologous to known allergens
in the human field, such as amylase/maltase (Cul s1, Cul n8,
Cul o1), hyaluronidase (Cul n2, Cul o2) antigen-5 (Cul n 1,
Cul o 3), D-7-related proteins (Cul n 9, Cul o 6, Cul o 2b),
cysteine protease (Cul n 3) and serine protease inhibitor (Cul
o 1b). Nevertheless, identities at the amino acid level between
these Culicoides allergens and the homologous allergens rele-
vant in human allergy are not very high with, for example,
44% for hyaluronidase (Api m2, a major allergen of bee
venom) and cross-reactivity is probably rather unlikely to
occur. In a pilot study, it was observed that sera from horses
with high IgE levels to recombinant C. nubeculosus hyaluro-
nidase did not bind to the corresponding allergen from bees
(E. Marti, unpublished data). Additionally, Culicoides sali-
vary gland proteins with yet unknown function have been
identified as allergens relevant for IBH (Cul n 4- 7, Cul n 10,
Cul o 5 and Cul o 7). All these recombinant allergens elicit
immediate-type reactions in IBH-affected horses in intrader-
mal tests indicating sensitization.
IDT, CAST and immunoblots have revealed that a propor-
tion of the IBH-affected horses concurrently react with Simu-
lium extracts. IgE-binding salivary gland proteins from S.
vittatum were identified using phage surface display technol-
ogy and expressed as recombinant proteins (69). These pro-
teins showed sequence similarities to antigen 5-like protein
(Sim v 1), to a serine protease inhibitor (Sim v 2) and to
alpha-amylase (Sim v 3 and Sim v 4) (Table 1). Furthermore,
three S. vittatum erythema proteins (SVEPs) were identified.
IBH-affected horses had significantly higher IgE levels than
controls against r-Sim v 1, 2, 3, 4, whereas the r-SVEP
showed only marginal IgE binding. First studies using
immunoblots suggested that the antigen 5-like proteins from
C. nubeculosus (Cul n 1) and S. vittatum (Sim v 1) are cross-
reactive, although they only display 49% identity at the
amino acid level (69). Cross-reactivity was confirmed by
extended inhibition ELISA experiments clearly showing that
Sim v 1 in fluid phase is able to strongly inhibit binding of
serum IgE to solid-phase-coated Cul n 1 in a concentration-
dependent manner and vice versa (70). This study indicates
that the reactivity to black flies observed in some of the IBH-
affected horses is probably due to cross-reactivity and is sec-
ondary to Culicoides sensitization. Hypersensitivity reactions
to other insects are much less well studied in horses, but they
seem to play a role in equine recurrent urticaria and atopic
dermatitis. Horses affected with these conditions show posi-
tive IDT reactions to insect extracts more frequently than
control horses, although positive IDT reactions are also com-
mon in those controls (71). Depending on the study, positive
reactions to Aedes, black ant, horse fly, black fly, deer fly or
mosquito were found more frequently in patients than in
healthy controls. To our knowledge, sera from these horses
have never been tested for IgE binding to recombinant insect
allergens.
Horses develop respiratory and skin diseases due to pollen
allergens and show positive intradermal test results against
tree, grass and weed pollens (61) as well as pollen-specific
serum IgE (5, 72). Most reactions on intradermal testing with
grass pollen extracts were observed against Bermuda grass,
with weed extracts against sage mix (both in approximately
half the horses) and with tree pollen extracts against olive,
cedar, orange and alder trees (61). Positive correlations
between symptom severity and exogenous factors such as cli-
matic conditions, rainfall or seasonal pollen counts were
observed (73).
Exposure to mouldy hay plays a central role in equine
recurrent airway obstruction (RAO). Challenge with mouldy
hay or mould extracts leads to exacerbation of clinical symp-
toms. Although non-IgE-mediated mechanisms have been
implicated in the pathogenesis of RAO, there is also evidence
of sensitization to fungal allergens. Basophil histamine release
in response to stimulation with fungal allergens or hay
extract is higher in RAO-affected horses than in healthy con-
trols (74). Histamine release from pulmonary mast cells after
in vitro stimulation with fungal extracts was also significantly
higher in RAO-affected horses than healthy controls.
Schmallenbach et al. (1998) found increased Aspergillus
fumigatus extract-specific IgE and IgG responses in bron-
choalveolar lavage fluid of RAO-affected horses (75). Other
studies detected IgE antibodies specific for crude extracts of
Aspergillus fumigatus, Alternaria alternata and Penicillium
notatum, and the recombinant allergens Asp f 7,8, 9 and Alt
a 1 in BAL or serum (59, 76). IgE specific for crude mould
extracts was not different between healthy and affected
horses. In contrast, IgE against recombinant allergens was
detectable only in some horses – more frequently in RAO-
affected horses than in healthy controls. IgG antibodies
specific for the A. fumigatus extract were also detected in
both healthy and RAO horses with no significant differences
between the two groups, while RAO horses had significantly
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higher IgG responses against Asp f 8 than healthy horses
(59, 76). It is possible that IgE plays a role only in a subset
of RAO patients with genetic predisposition. Scharrenberg
et al. (2010) detected Asp f 7-specific IgE, IgGa, IgGb and
IgG(T) in two families from RAO-affected sires. No differ-
ences in total IgE, but significant differences in Asp f 7-speci-
fic IgE levels were found between RAO-affected animals and
controls, but also between the offspring of one stallion vs the
other (77). Genetic analysis identified several quantitative
trait loci associated with this phenotype. Although fungal
extracts as well as recombinant allergens have been used to
detect IgE responses against moulds in horses, it is not
known which proteins are major allergens in horses. The
authors could also not find reports of immunotherapy using
fungal allergens in horses.
Outlook and future trends
The number of pets in total and thus also the number of ani-
mals with diagnosed allergies are continuously increasing and
so are the awareness of and the interest in veterinary allergol-
ogy. It can be assumed, that increased awareness of the differ-
ences will enhance the transfer of recent trends in human
allergology to veterinary medicine. This will be facilitated by
the increased economic impact of veterinary medicine for pets
as well as for farm animals. This fact can be exemplified by
the discovery of novel allergens playing a key role in Culi-
coides-mediated allergic skin disease of horses. The identifica-
tion of these allergens was pursued over a 20-year period and
enabled the discovery of new allergens in human medicine.
The direct consequence of this availability is the development
of component-specific diagnostics tools to identify insect-bite
hypersensitivity in the horse and to perform research towards
specific immunotherapies with recombinant insect allergens to
desensitize horses suffering from this disease. More recent
approaches, in silico based or derived from the wet laboratory,
such as integrated approaches using genomic, transcriptomic,
proteomic and metabolomic data, will be more and more fre-
quently used, as the overall price erosion of these high-
throughput technologies will make them increasingly available
for use in veterinary medicine. Identification of and testing for
major allergens in each species may allow one to differentiate
clinically nonrelevant extract-specific IgE from relevant IgE
directed against the true allergens and thus improve the diag-
nostic accuracy of allergy testing and probably also the suc-
cess of allergen-specific immunotherapy. The usage of recent
technologies in veterinary medicine will thus provide novel
insights into the basic immunological mechanisms of pet
mammals, leading to the discovery of novel biomarkers, iden-
tification of new allergens, and thus to novel diagnostic tools
and therapeutic concepts. The formation of a veterinary aller-
gology special interest group within the EAACI is giving new
impetus to the field of veterinary allergy, while human allergy
may also benefit from the veterinary field as allergic diseases
in domestic species can represent natural models of allergy.
Unlike mouse models, dogs and cats kept as pets are generally
exposed to the same environmental influences as humans and
thus are much better mirrors of the human disease counter-
part. New diagnostic and therapeutic tools successful in veteri-
nary practice may be more applicable to the human field than
those developed in the laboratory. Thus, there is great poten-
tial in the collaboration of human and veterinary allergology.
An increased and facilitated interaction of specialists in both
fields, one of the aims of the EAACI Interest Group ‘Compar-
ative and Veterinary Allergology’, may benefit all and help in
advancing allergology worldwide.
Conclusion
Despite the increasing awareness of the importance of aller-
gic diseases in animals, the discipline of veterinary allergol-
ogy limps behind its human counterpart. There are several
reasons for this. The full methodology available in human
allergology often cannot be transferred to other species
without adjustments. For example, simple development of
an ELISA to detect allergen-specific IgE often suffered from
the limited availability of well-characterized detection mole-
cules such as monoclonal antibodies specific for the species
of interest. However, for dogs and horses, some of those
reagents are now available. For some animals, the exact
interaction of defined immunoglobulin isotypes with their
high- and low-affinity receptors on cells of the immune sys-
tem is not elucidated to the same degree as in humans.
Nevertheless, during the recent years, increasing effort led
to novel reagents and technologies and stimulated research
in the field of veterinary allergology, resulting in the identi-
fication of novel relevant allergens and deeper understand-
ing of animal-specific pathogenesis of allergic diseases. This
availability of methodologies for diagnosis and therapy,
together with an increasing awareness for allergic diseases in
veterinary practice as well as in the general population of
companion animal owners, facilitated this development.
Between one in two (UK and France) and one in three
households (Germany) have pets (http://www.ifaheu
rope.org/companion-animals/about-pets.html: accessed 7.7.14),
and the potential economical impact can easily be deduced
from the large numbers of pets living in European house-
holds (260 Mio, without fish and reptiles). Veterinary aller-
gology has become an important, dedicated veterinary
discipline, and allergic disorders of man’s best friend slowly
gain the awareness they deserve beyond being mere models
for human allergies.
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